world haematology & medical oncology conference 2018

Starts On: 28/05/2018
Ends At: 29/05/2018
Country: Japan
City: Osaka
Contact Email:
Contact Phone: +1 7025085200
Conference Website
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)



About Conference

Kindcongress invites all the participants from all over the world to attend  International Conference on Haematology and Oncology during May 28- 30, 2018 in Osaka, Japan. The conference will be organized around the theme An Eye towards Haematology and Oncology

Why Attend?

With members from around the world focused on learning about Hematology and Blood Disorders; this is your best opportunity to reach the largest assemblage of participants from the Cancer community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new developments and research, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Haematology & in oncology, treatment, and surgery involved are hallmarks of this conference.

Haematology and Oncology 2018 welcomes immunologists, pathologists, hematologists, oncologists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of it.

Target Audience:

  •  Business Entrepreneurs Public
  •  Health Professionals
  •  Drug Manufacturing Companies
  •  Radiation Therapist
  •  Oncology Societies
  •  Clinical Researchers
  •  Leading world Doctors
  •  Surgical and Medical Hematologist
  • Young Researchers
  • Students & Delegates

Conference Highlights:

  • Haematology
  • Haematologic-Oncology
  • Blood Disorders and Blood oncology
  • Leukemia Immunology
  • Haemato Immunology &Stem Cell Research
  • Haematological Malignancies
  • Biomarkers
  • Advances in Bone Marrow Transplantation and surgery
  • Oncology
  • Cancer Epidemiology
  •  Gynecologic oncology

Important Dates:

Abstract submission open July 02, 2017
Registration opens July 10, 2017
Early bird registration October 25, 2017
On spot registration May 28, 2018


Sessions/ Tracks

Track 1: Hematology

Erythrocytes are also called as red platelets which convey oxygen to the body and gather carbon dioxide from the body by the use of haemoglobin and its life expectancy of 120 days. At the edge the leucocytes helps in ensuring the healthy cells in light of the fact that the W.B.C (leucocytes) go about as the defending cells in protecting the immune system from the outside cells. Formation of blood cellular components are called as Haematopoiesis and all the cellular blood segments are gotten from haematopoiesis stem cells in a healthy individual almost 1011–1012 fresh blood cells are produced these assistance in steady peripheral circulation. In the event that there is increments of R.B.C in the body these causes polycythemia these can be measured through haematocrit level.

Track 2: Hematologic-Oncology

Hematologic Oncology is the branch of medical study about the diagnosis, prevention, treatment, and avoidance of disease identified with blood. Hematology incorporates the study of etiologist includes treating a disease that influences the production of blood and its parts, for example, platelets, hemoglobin, blood proteins, bone marrow, platelets, veins, spleen, and the component of coagulation. The research facility work that goes into the study of blood is much of the time performed by a medical technologist or therapeutic lab researcher. Haematologists also conduct a study in oncology and work with oncologists, individuals who may specialize just in that field rather than both-the therapeutic treatment of the tumor. There are different disorders that people are influenced by Hematology. A couple of these different type of blood conditions that are looked at incorporate anemia, hemophilia, general blood clots, bleeding disorders, and so forth. With respect to related blood diseases, for example, Leukemia, myeloma, and lymphoma, these are more serious cases that should be analyzed.

Track 3: Blood Disorders And Blood Oncology

Iron deficiency is the most well-known sort of blood issue we treat. Patients with anemia have an insufficiency of oxygen-rich red platelets or their red platelets don’t work appropriately. A low level of hemoglobin, the iron-rich protein that conveys the oxygen in red platelets, flags the condition. Anaemia can be constant, or a brief condition caused by other medical problems, including growth treatment, hepatitis C, and HIV/AIDS. Anemia every now and again stays undiscovered in light of the fact that it is a fundamental state of other medical problems, including growth, cardiovascular malady, diabetes, HIV/AIDS, fiery entrail sickness, unending kidney infection, and rheumatoid joint pain. Hemophilia is a rare typically inherited blood disorder, commonly acquired blood issue in which the blood does not appropriately clump and causeintemprate dying, which can make harm organs, joints, and tissues. The patient may experience the ill effects of the site of damage or from inward dying. Coagulating Disorders Hematologists likewise treat conditions identified with the proteins that trigger draining and thickening, including thrombosis (thickening) and hemostasis (dying). Thrombosis refers to the formation of abnormal blood clots that become embedded in a major vein or artery, blocking blood circulation. Blood clots can cause pain, swelling, or warmth in the affected area, and can be life-threatening. Hemostasis is the process of controlling bleeding. Blood Cancers Cancerous blood conditions include leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, and multiple myeloma.

Track 4: Leukemia Immunology

Cancer immunology is a branch of immunology that studies interaction between the immune system and cancer cells (likewise called tumours or malignancies). It is a developing field of research that plans to find innovative malignancy immunotherapies to treat and retard movement of disease. The immune system reaction, including the acknowledgment of disease particular antigens, is specifically compelling in the field as knowledge gained drives the development of targeted therapy (such as new vaccines and antibody therapies) and tumour marker-based diagnostic tests.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *